NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Renaissance BioScience's Mexican Patent for Yeast-Based RNA Technology
TL;DR
Renaissance BioScience's new patent strengthens its IP portfolio, offering competitive production costs for RNA-based biopesticides that outperform chemical alternatives.
Renaissance BioScience's yeast-based platform enables low-cost RNA production and delivery, integrating with existing farming practices to create targeted RNAi biopesticides.
This technology reduces environmental harm by replacing broad-spectrum pesticides with precise biopesticides, making agriculture safer and more sustainable.
A Canadian company now holds patents in three countries for yeast that produces RNA molecules, opening possibilities beyond pest control.
Found this article helpful?
Share it with your network and spread the knowledge!
Renaissance BioScience Corp. has been granted a patent by the Mexican patent office for its yeast-based platform technology that enables low-cost production and effective delivery of RNA.
This is the third patent issued for the company's RNA technology, following earlier grants in China and Australia, and it expands Renaissance's robust intellectual property portfolio for yeast-based technology across multiple markets.
The technology uses a yeast-based platform to produce, protect, and deliver next-generation RNA bioactive molecules, enabling low-cost production and effective delivery of RNA.
The most advanced application is a suite of RNAi-based biopesticide products that provide precise, targeted pest control with a strong environmental safety profile compared to broad-spectrum chemical pesticides.
These products offer precise, targeted pest control with a strong environmental safety profile compared to broad-spectrum chemical pesticides, maintain competitive production costs at scale, and integrate smoothly into current farming practices and equipment.
Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented that the patent confirms the novelty and importance of their yeast-based RNA technology for producing, protecting, and delivering next-generation RNA bioactive molecules, with opportunities across multi-billion-dollar commercial markets beyond biopesticides.
Renaissance BioScience Corp. is based in Vancouver, Canada, and is a global leading yeast bioengineering company that develops innovative, market-ready, functional microorganisms to provide cost-effective solutions for environmental and industrial challenges in agriculture, animal and human health, food, energy, and more.
Patents have been issued in China and Australia, with additional jurisdictions pending, according to the content.
More information is available at www.renaissancebioscience.com.
Curated from 24-7 Press Release
